Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02146573 · ClinicalTrials.gov registry record · NA

Pediatric Continuity Care Intensivist

A NA study of Critical Illness, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
276
Enrollment target
1
Study location

NCT02146573: Completed NA study of Critical Illness, sponsored by Children's Hospital of Philadelphia.

NCT02146573 is a NA study of Critical Illness that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 276 participants, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02146573, a NA study of Critical Illness, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
276 participants
Enrollment target
1
Study location

Study Summary

This study will implement and evaluate the effects of a pediatric continuity care intensivist program. This study will determine the impact of an additional pediatric intensive care unit (PICU) intensivist on outcomes at the patient and family level. It will also evaluate the training program to prepare the continuity care intensivist (CCI).

Primary Outcome

Length of stay as measured by the Virtual PICU system (VPS) in the PICU.

Conditions Studied

Interventions

  • BEHAVIORAL Continuity Care Intensivist Communication Training
  • BEHAVIORAL Continuity Care Intensivist (CCI) Provider Program

Study Locations (1)

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2014-05
Est. Completion 2018-12
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT02146573 record still lists

NCT02146573 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Continuity Care Intensivist Communication Training is the first listed.

NCT02146573 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02146573 about?

NCT02146573 is a clinical study titled "Pediatric Continuity Care Intensivist". This study will implement and evaluate the effects of a pediatric continuity care intensivist program. This study will determine the impact of an additional pediatric intensive care unit (PICU) intensivist on outcomes at the patient and family level. It will also evaluate the training program to pre...

What is the current status of trial NCT02146573?

This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2014-05. Estimated completion is 2018-12.

What conditions does trial NCT02146573 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT02146573?

The interventions under investigation include: Continuity Care Intensivist Communication Training (BEHAVIORAL), Continuity Care Intensivist (CCI) Provider Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02146573?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02146573 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02146573's enrollment target sits among peer trials

276 42nd of 91 higher than 50 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01371630 · 276 participants · Phase 1

    Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

  • NCT04192344 · 276 participants · Phase 1

    A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

  • NCT05294991 · 276 participants · NA

    Wellness App for Sleep Disturbance in Hematological Cancer Patients

  • NCT05610852 · 276 participants · NA

    Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02146573, the US trial registry maintained by the National Library of Medicine. NCT02146573 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.